FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 304:251-258 January 29, 1981 Number 5 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied the effect of th bite acid sequestrant colestipol, alone and in combination with clofibrate or niacin, in patients with heterozygous familial hypercholesterolemia who were given a diet low in cholesterol and saturated fat. With colestipol alone, mean cholesterol levels in serum decreased 16 to 25 per cent. The addition of clofibrate produced a total mean decrement of only 28 per cent. In contrast, serum cholesterol levels fell 45 per cent when colestipol as combined with niacin. Low-density-lipoprotein (LDL) cholesterol decreased 55 per cent with colestipol and niacin, whereas high-density-lipoprotein (HDL) cholesterol increased. Mean LDL cholesterol was lower in patients given this regimen than in matched normal controls eating an unrestricted diet. Tendinous xanthomas, measured by quantitative xeroradiography, were significantly reduced (P < 0.01), indicating that this regimen mobilized cholesterol from tissue pools with slow turnover. Colestipol plus niacin promises to be useful in the treatment of patients at high risk from elevated levels of LDL.

This article has been cited by other articles:

• Beeharry, D, Coupe, B, Benbow, E W, Morgan, J, Kwok, S, Charlton-Menys, V, France, M, Durrington, P N (2006). Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis. Ann Rheum Dis 65: 312-315 [Abstract] [Full Text]  
• Basu, T. K., Mann, S. (1997). Vitamin B-6 Normalizes the Altered Sulfur Amino Acid Status of Rats Fed Diets Containing Pharmacological Levels of Niacin without Reducing Niacin's Hypolipidemic Effects. J. Nutr. 127: 117-121 [Abstract] [Full Text]  
• Hofer, T., Weissfeld, J. (1994). Designing a Simpler High Blood Cholesterol Case Detection Strategy: Are the Advantages of the NCEP Protocol Worth the Complexity?. Med Decis Making 14: 357-368 [Abstract]  
• Weissfeld, J. L., Weissfeld, L. A., Holloway, J. J., Bernard, A. M. (1990). A Mathematical Representation of the Expert Panel's Guidelines for Nigh Blood Cholesterol Case-finding and Treatment. Med Decis Making 10: 135-146 [Abstract]  
• LaRosa, J. C. (1982). The Mechanism of Action of Lipid-Lowering Drugs. ANGIOLOGY 33: 562-576  
• Brown, M., Kovanen, P., Goldstein, J. (1981). Regulation of plasma cholesterol by lipoprotein receptors. Science 212: 628-635 [Abstract]